These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 21427551)

  • 1. Pharmacogenomic contribution to drug response.
    Watson RG; McLeod HL
    Cancer J; 2011; 17(2):80-8. PubMed ID: 21427551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenomics of colorectal cancer prevention and treatment.
    Nguyen H; Tran A; Lipkin S; Fruehauf JP
    Cancer Invest; 2006 Oct; 24(6):630-9. PubMed ID: 16982469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacogenomic approaches for prevention of drug toxicity in cancer chemotherapy].
    Hasegawa Y
    Gan To Kagaku Ryoho; 2003 Mar; 30(3):325-33. PubMed ID: 12669388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenetics in chemotherapy of colorectal cancer.
    Henriette Tanja L; Guchelaar HJ; Gelderblom H
    Best Pract Res Clin Gastroenterol; 2009; 23(2):257-73. PubMed ID: 19414151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular predictors of response to therapy for breast cancer.
    Galanina N; Bossuyt V; Harris LN
    Cancer J; 2011; 17(2):96-103. PubMed ID: 21427553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Germline genetic variation, cancer outcome, and pharmacogenetics.
    Coate L; Cuffe S; Horgan A; Hung RJ; Christiani D; Liu G
    J Clin Oncol; 2010 Sep; 28(26):4029-37. PubMed ID: 20679599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenomics and -genetics in colorectal cancer.
    Pohl A; Lurje G; Manegold PC; Lenz HJ
    Adv Drug Deliv Rev; 2009 May; 61(5):375-80. PubMed ID: 19100300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenetic aspects in treatment of colorectal cancer--an update.
    Stoehlmacher J; Goekkurt E; Lenz HJ
    Pharmacogenomics; 2003 Nov; 4(6):767-77. PubMed ID: 14596640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacogenetics and tumor sensitivity of antineoplastic agents. Application to colorectal cancer].
    Milano G
    Rev Prat; 2008 May; 58(10):1056-9. PubMed ID: 18652401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and pharmacogenomics in breast cancer chemotherapy.
    Marsh S; Liu G
    Adv Drug Deliv Rev; 2009 May; 61(5):381-7. PubMed ID: 19100797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Individualized chemotherapy treatment for breast cancer: is it necessary? Is it feasible?
    Pusztai L; Rouzier R; Wagner P; Symmans WF
    Drug Resist Updat; 2004 Dec; 7(6):325-31. PubMed ID: 15790543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Personalized systemic treatment for breast cancer patients: is it a reality?
    Shimizu C; Fujiwara Y
    Breast Cancer; 2008; 15(2):141-4. PubMed ID: 18274835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenetic tests in cancer chemotherapy: what physicians should know for clinical application.
    Lee SY; McLeod HL
    J Pathol; 2011 Jan; 223(1):15-27. PubMed ID: 20818641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular markers in the treatment of metastatic colorectal cancer.
    Wilson PM; Labonte MJ; Lenz HJ
    Cancer J; 2010; 16(3):262-72. PubMed ID: 20526105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular predictors of response to chemotherapy in colorectal cancer.
    Dienstmann R; Vilar E; Tabernero J
    Cancer J; 2011; 17(2):114-26. PubMed ID: 21427555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Problems associated with molecular targeted drugs for cancer].
    Kawaishi M; Koizum F; Nishio K
    Gan To Kagaku Ryoho; 2006 Oct; 33(10):1373-9. PubMed ID: 17033223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Developments in cancer management by innovative genomics. 2006 report of the National Cancer Consortium].
    Tímár J; Kásler M; Kátai J; Soós M; Mathiasz D; Romány A; Patthy L; Kovács G; Józsa A; Szilák L; Forrai T
    Magy Onkol; 2006; 50(4):349-59. PubMed ID: 17216011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interpreting disparate responses to cancer therapy: the role of human population genetics.
    Maitland ML; DiRienzo A; Ratain MJ
    J Clin Oncol; 2006 May; 24(14):2151-7. PubMed ID: 16682733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Capecitabine pharmacogenetics: historical milestones and progress toward clinical implementation.
    Syn N; Lee SC; Goh BC; Yong WP
    Pharmacogenomics; 2016 Oct; 17(15):1607-1610. PubMed ID: 27676641
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacogenetic Predictors of Response.
    Hertz DL; Rae JM
    Adv Exp Med Biol; 2016; 882():191-215. PubMed ID: 26987536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.